BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, December 11, 2025
Home
»
Newsletters
» BioWorld
BioWorld
July 29, 2002
View Archived Issues
Ricerca's Infectious Disease Area Established Via Deal With Genset
Read More
Transgenic Mouse Experiments Show Clusterin Protein Has Hand In Alzheimer's Plaque Formation
Read More
Scios Planning Private Offering Of $125M In Convertible Notes
Read More
Other News To Note
Read More
Quarterly Earnings Reports
Read More
OGS Gains European Approval, Partner For Gaucher's Product
LONDON - Oxford GlycoSciences plc said Friday it received approval in Europe for Vevesca, an oral treatment for Gaucher's disease that was turned down by the FDA on June 24. (BioWorld Today)
Read More
